Patel Lab
- Publications & Media
- Team
- Projects
- Dr. Sandip Patel Bio
Dr. Sandip Patel's Google Scholar page:
https://scholar.google.com/
Dr. Sandip Patel's PubMed page:
https://pubmed.ncbi.nlm.nih.gov/?term=Patel+SP&sort=fauth
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers Mol Cancer Ther (2017) 16 (11): 2598–2608.
PD‑1–PD‑L1 immune-checkpoint blockade in B‑cell lymphomas Nature (2017) Vol. 14
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based ImmunotherapyClin Cancer Res (2017) 23 (19): 5729–5736.
Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents
Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies
Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapies
Sandip Patel, MD, considers immunotherapy combinations and the likelihood of severe adverse events
Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life